Earnings Week Ahead: TSLA, GOOG, GE, BA, PG, PEP, ABBV, V, T, AAL, LUV, INTC, IBM, and More
Over 70% of Companies Deliver EPS Wins This Week: Earnings Scorecard
Earnings Preview: Merck & Co to Report Financial Results Pre-market on April 24
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $89 to $115
Assessing Merck & Co: Insights From 9 Financial Analysts
Is Merck & Co., Inc. (MRK) The Dirt Cheap Stock To Invest In Now?
Merck Price Target Maintained With a $115.00/Share by Guggenheim
$MRK Stock Is up 2% Today. Here's What We See in Our Data.
Unusual Options Activity: PDD, KR and Others Attract Market Bets, PDD V/OI Ratio Reaches 238.7
Merck & Co Analyst Ratings
Leerink Partners Adjusts Price Target on Merck to $115 From $113, Keeps Outperform Rating
Merck & Company (MRK) Receives a Buy From Guggenheim
Agilent Says Diagnostic Assay Gets European IVDR Certification in Gastric Cancer
Express News | Merck & Co Inc : BMO Cuts Target Price to $89 From $96
Merck & Co Options Spot-On: On April 16th, 78,609 Contracts Were Traded, With 682.68K Open Interest
Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued Quality Stock to Buy Now?
Trump Targets Medicare Price Negotiations in New Executive Order
Merck & Co Options Spot-On: On April 15th, 55,322 Contracts Were Traded, With 667.28K Open Interest
Price Over Earnings Overview: Merck & Co